NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS)
$61.65 3.95 (6.8458%)
Analysed NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS) News Sources
Novozymes Dividend Increase And Valuation Discount Catch Investor Attention
04-04-2026
yahoo.com
FUL or NVZMY: Which Is the Better Value Stock Right Now?
31-03-2026
yahoo.com
Resolutions from the Annual General Meeting 2026
23-03-2026
yahoo.com
Invitation to the 2026 Annual General Meeting
26-02-2026
yahoo.com
Novonesis (Novozymes) B (NVZMF) Full Year 2025 Earnings Call Highlights: Strong Organic Sales ...
25-02-2026
yahoo.com
Is Novozymes (CPSE:NSIS B) Pricing Reflect Recent Valuation Concerns Accurately
16-02-2026
yahoo.com
Synthetic Biology and Bioprocessing Market Reaches Multi-Billion Scale with High-Throughput Fermentation and Engineered Microbes Driving Innovation
09-02-2026
yahoo.com
Cabot Expands Mexico Footprint With MXCB Facility Buyout
05-02-2026
yahoo.com
CENX's Hawesville Site Sale to Facilitate AI Data Campus Buildout
04-02-2026
yahoo.com
NVZMY vs. HWKN: Which Stock Is the Better Value Option?
03-02-2026
yahoo.com
What is the current price of NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS)?
The current price of NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS) is $61.65.
NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS) since the previous trading day is $3.95.
NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS) since the previous trading day is 6.8458%.
What is the most recent average sentiment score for NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS)?
The most recent average sentiment score for NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS) is 58 out of 100.
What is the most recent average sentiment for NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS)?
The most recent sentiment for NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS) is .
SEC-8K** Filing Available For NOVONESIS (NOVOZYMES) B (NVZMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.